ZELTIQ Aesthetics downgraded to Neutral from Overweight at JPMorgan

JP Morgan downgraded ZELTIQ citing the Q4 miss and disappointing guidance. Price target lowered to $9 from $16. Note that shares were also downgraded at Goldman.